share_log
Reuters ·  Jul 22 16:45
Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment